1 completed, 1 terminated. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Terminated 1 |
Follow danaparoid: new trials by email Literature Review of danaparoid trials Research Report on danaparoid
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban Danaparoid Sodium, Argatroban - Heparin-induced Thrombocytopenia | Phase 3 | Terminated | Aspen Global Incorporated | 7 | 2019-05-16 | 2022-12-08 |
| Retrospective Registry of Patients With Acute Heparin-induced Thrombocytopenia Type II lepirudin, danaparoid, argatroban - Acute HIT II (Heparin-induced Thrombocytopenia Type II) | Completed | GlaxoSmithKline | 195 | 2009-02-01 | 2017-07-06 |
Aspen Global Incorporated (1) · GlaxoSmithKline (1)
Bosnia and Herzegovina (1) · Canada (1) · France (1) · Germany (1) · Italy (1) · Poland (1) · Russia (1) · Serbia (1) · United States (1)